Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal of Chemotherapy (Florence, Italy)
|
September 11, 2024
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, et al.
Immunotherapy
|
April 21, 2026
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
Ali Kaan Güren, Nazım Can Demircan, Özge Gümüşay, et al.
Journal of Cancer Research and Clinical Oncology
|
April 17, 2023
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, et al.
Scientific Reports
|
March 9, 2024
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 18, 2020
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
Nir Peled, Roni Gillis, Saadettin Kilickap, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 24, 2024
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
Cevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, et al.
Discover Oncology
|
March 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study
Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur, et al.
Cancers
|
June 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
Bahadır Köylü, Özde Melisa Celayir, Harun Muğlu, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal of Chemotherapy (Florence, Italy)
|
September 11, 2024
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, et al.
Immunotherapy
|
April 21, 2026
Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab
Ali Kaan Güren, Nazım Can Demircan, Özge Gümüşay, et al.
Journal of Cancer Research and Clinical Oncology
|
April 17, 2023
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, et al.
Scientific Reports
|
March 9, 2024
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 18, 2020
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
Nir Peled, Roni Gillis, Saadettin Kilickap, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 24, 2024
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing
Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, et al.
Clinical Genitourinary Cancer
|
June 25, 2026
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
Cevat İlteriş Kıkılı, Murat Araz, Yüksel Ürün, et al.
Discover Oncology
|
March 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study
Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur, et al.
Cancers
|
June 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study
Bahadır Köylü, Özde Melisa Celayir, Harun Muğlu, et al.
Page
of 15